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ABSTRACT
Ribosomes are key macromolecular protein synthe-
sis machineries in the cell. Human ribosomes have
so far not been studied to atomic resolution
because of their particularly complex structure as
compared with other eukaryotic or prokaryotic ribo-
somes, and they are difficult to prepare to high
homogeneity, which is a key requisite for high-reso-
lution structural work. We established a purification
protocol for human 80S ribosomes isolated from
HeLa cells that allows obtaining large quantities of
homogenous samples as characterized by biophys-
ical methods using analytical ultracentrifugation
and multiangle laser light scattering. Samples
prepared under different conditions were
characterized by direct single particle imaging
using cryo electron microscopy, which helped
optimizing the preparation protocol. From a small
data set, a 3D reconstruction at subnanometric
resolution was obtained showing all prominent
structural features of the human ribosome, and re-
vealing a salt concentration dependence of the
presence of the exit site tRNA, which we show is
critical for obtaining crystals. With these well-
characterized samples first human 80S ribosome
crystals were obtained from several crystallization
conditions in capillaries and sitting drops, which
diffract to 26 A˚ resolution at cryo temperatures and
for which the crystallographic parameters were
determined, paving the way for future high-
resolution work.
INTRODUCTION
Ribosomes are composed of two subunits, the large (60S/
50S) and the small (40S/30S) ribosomal subunits, which
assemble together to form the functional 80S and 70S in
eukaryotes and prokaryotes, respectively. Each subunit
has protein and ribosomal RNA (rRNA) components
with a relatively stable rRNA/protein ratio of 2:1 in cyto-
solic mammalian and bacterial ribosomes. The overall
structure of the ribosome is conserved in all species con-
sisting of the three tRNA binding sites [aminoacyl (A),
peptidyl (P) and exit (E)], the GTPase center and the
peptidyl transferase center. However, apart from the
conserved core, eukaryotic ribosomes are more complex
and contain many more proteins (26 extra) and longer
rRNA (including long expansion segments, ES) (1).
These ES have been hypothesized to allow ribosome
docking on the endoplasmic reticulum, possibly providing
scaffolding sites to bind additional proteins and form eu-
karyote-speciﬁc inter-subunit bridges (2). Also, function-
ally, the eukaryotic ribosomes have many more factors
involved in every step of translation (initiation, elong-
ation, termination and recycling) reﬂecting a high level
of regulation (3–6).
The crystal structures of eukaryotic ribosomes from
Saccharomyces cerevisiae 80S at 3.0 A˚ (7), Tetrahymena
thermophila 60S at 3.5 A˚ and 40S at 3.9 A˚ (8,9) have
highlighted the additional protein and rRNA compo-
nents and precisely assigned their positions. The more
complex higher eukaryotic ribosomes have been exten-
sively studied by single particle cryo electron microscopy
(cryo-EM) providing the ﬁrst structure of the wheat
germ ribosome obtained at 38 A˚ (10), which recently
reached 5.5 A˚ resolution (11). Cryo-EM maps for
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mammalian ribosomes such as canine, human (HeLa
cell) and rabbit ribosomes (12–15) are available at rela-
tively low resolutions of 8–15 A˚ but were the pioneer
studies that allowed localizing eukaryote-speciﬁc
proteins such as RACK1, rpS27e, rpS25e, rpL30e
(16,17). Recently, the cryo-EM structures of human
and drosophila ribosomes were elucidated in more
detail with a resolution range of 5–9 A˚, with the latest
structure of the human ribosome reaching the 4–5 A˚
range (18). The availability of only a handful of eukary-
otic ribosome structures (19–22) emphasizes the difﬁ-
culty of appropriate puriﬁcation, the limiting point
being the availability of homogenous samples in large
quantities required both for cryo-EM and
crystallography.
Studying human ribosomes as opposed to ribosomes
from other species is crucially important for understand-
ing the mechanism of antibiotic action and selectivity
with respect to ribosomes from various pathogenic
bacteria, an ever increasing problem with the constantly
growing occurrence of antibiotic resistance (23,24). The
previous structures of prokaryotic ribosomes with anti-
biotics like paramomycin, streptomycin, tetracycline,
hygromycin B, etc. have helped to elucidate the struc-
tural basis for their efﬁcacy (25,26) and the species-
speciﬁc interactions between ribosomes and antibiotics
(27,28). Obtaining accurate information on the human
ribosome would provide a prospect of developing
speciﬁc antibiotics preferentially targeting the function
of the prokaryotic ribosome with improved efﬁciency
and reduced side effects, i.e. provide the molecular
basis of cross-reactivity of existing or future antibiotics,
which would be useful for the discovery of novel antibi-
otics. Human ribosomes have been puriﬁed earlier, from
HeLa cells and placenta or blood (18,29) as separate
subunits and reconstituted to 80S (30) for biochemical
and cryo-EM analysis. However, to our knowledge,
they have not yet been crystallized in the form of the
fully assembled, endogenous 80S complex, which would
be a key advance to get atomic level information. This
would be crucial in particular for antibiotic complexes
to understand the binding of those ligands that induce
side effects, and of other and future drugs targeting
the human ribosome (as accompanying drugs to reduce
cellular activity such as required in the case of the
treatment of cancer). Here, we establish a protocol
to purify 80S ribosomes from HeLa cells in large
amounts and describe the sample optimization by moni-
toring the homogeneity through sucrose gradients,
Analytical Ultracentrifugation (AUC), Size Exclusion
Chromatography Multiangle Laser Light Scattering
(SEC-MALLS) and cryo-EM, which allowed obtaining
crystallizable material. The crystals obtained here were
characterized at synchrotron X-ray sources with respect
to their crystallographic parameters such as cell param-
eters, space group, solvent content, etc., which represents
essential information for future high-resolution work
using crystallography.
MATERIALS AND METHODS
Detailed protocol of ribosome puriﬁcation from HeLa
cells
Equipments required: 10-l ﬂasks for cell culture, SW-28
rotor, Type 50.2 Ti Beckman-Coulter rotor, GE SG-50
Gradient maker, Econo UV Monitor (Biorad), a
Fraction Collector (Biorad), Econo Gradient Pump
(Biorad).
Deionized distilled water is used for buffer prepar-
ations, and complete protease inhibitor (Roche) is
added to all the buffers. Also, sucrose solution must
be treated with bentonite after preparation with buffer
A to inhibit ribonucleases (31,32) if present. Buffer A
contains 20mM Tris, pH 7.5, 2mM Mg(OAc)2, 150mM
KCl. Buffer B contains 20mM Tris, pH 7.5, 6mM
Mg(OAc)2, 150mM KCl, 6.8% sucrose, 1mM DTT,
RNasin Plus RNase Inhibitor (Promega). Resuspension
buffer C contains 100mM KCl, 5mM Mg(OAc)2,
20mM HEPES, pH 7.6, 1mM DTT, 10mM NH4Cl.
For 60S and 40S subunit puriﬁcation a slightly
modiﬁed buffer A is required containing 20mM Tris,
pH 7.5, 2mM Mg(OAc)2, 500mM KCl. The role of
ion concentration in inter- and intra-subunit interaction
is discussed in the ‘Results’ section.
Step 1: HeLa cell preparation
HeLa cells are grown in suspension cultures (55 108
cells, 6 l) in Minimal Essential Media Spinner
Modiﬁcation (S-MEM; Sigma Aldrich) supplemented
with 7% newborn calf serum, 2mM Glutamine and
40 mg/ml gentamycin at 37C in 5% CO2 environment.
Once conﬂuent, they are serum-starved for 6 h to get a
synchronized cell population.
Step 2: Lysis and sucrose cushion
Cells are then lysed in freshly prepared lysis buffer con-
taining 15mM Tris, pH 7.5, 0.5% NP40 (Sigma-Aldrich),
6mM MgCl2, 300mM NaCl, RNAsin (Promega). After
30min incubation on ice, the lysate is centrifuged at
12 000g for 10min to remove debris, nuclei and
mitochondria (33). The supernatant is loaded on 30%
sucrose cushion prepared in Buffer A and centrifuged
for 16 h at 115 800g (50.2 Ti rotor) to get the crude ribo-
somal pellet (29,30). While loading the cushion, care must
be taken to not disturb the sucrose, and ensure slow
addition of the lysate to the 30% sucrose. This pellet is
resuspended in Buffer B to homogeneity. The presence of
nonresuspended particles in this solution can affect the
next step, and these particles must be removed by a
short centrifugation (10min at 10 000g). Only the super-
natant is used for the next step.
Step 3: Sucrose density gradient
Gradient preparation: SG 50 Gradient Maker (GE
Healthcare) is used to make a linear gradient of 15–
30%, wherein the higher % sucrose solution is loaded in
the mixing chamber and the lower % sucrose solution is
loaded in the other, allowing to mix slowly. The outlet is
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connected with a pump and sucrose is collected drop wise
from the outlet.
The supernatant is treated with 1mM puromycin for
30min at 4C (34) with intermittent mixing and loaded
on 15–30% sucrose gradient prepared in Buffer A. The
samples are centrifuged at 25 000 rpm for 11 h in a SW-
28 rotor and fractions are collected from bottom to top
using an Econo Gradient Pump (Biorad) with an Econo
UV Monitor (Biorad) and a Fraction Collector. The
sample absorbance is recorded using UV reader (Biorad)
and the peak corresponding to 80S is pooled for PEG20K
precipitation (7). A ﬁnal concentration of 7% PEG20K is
added to the pooled fractions, incubated on ice for 10min
and centrifuged at 17 400g for 10min. The pure ribosomal
pellet is dissolved in resuspension buffer C and ﬁltered
using 0.22mm ﬁlters (Millipore) for further analysis or
stored without ﬁltration on ice for 7 days for crystalliza-
tion. Snap freezing and storage is not advised. For
concentration calculations, 1 A260 unit corresponds to
20 pmol of 80S ribosome.
Analytical ultracentrifugation
Sedimentation velocity experiments were conducted using
Beckman Coulter ProteomeLab XL-I analytical ultracen-
trifuge using the 8-hole Beckman An-50Ti rotor at 4C for
samples in resuspension buffer (35). Sedimentation at
15 000 rpm was monitored by absorbance at 280 nm with
scans made at 4min intervals. The solution density and
viscosity for resuspension buffer were calculated using
SEDNTERP software. Data were analyzed using a c(s)
model in SEDFIT (Figure 1) (36).
Size exclusion chromatography multiangle laser light
scattering
The molecular weight and homogeneity of the sample was
checked using a SEC column coupled with MALLS Dawn
DSP detector (Wyatt Technology, Santa Barbara, CA,
USA) (Figure 1B). To prevent bacterial growth, 0.01%
sodium azide was added to the resuspension buffer,
which was then ﬁltered through 0.25mm ﬁlter membranes
(Millipore) before equilibrating the Superdex 200 10/300
analytical column (GE healthcare life sciences). The
system was operated at 20C, with a ﬂow rate of
0.75ml/min.
Single-particle cryo-EM
For cryo-EM analysis, 80S ribosome samples were de-
posited on Quantifoil 2/2 holey carbon ﬁlm, blotted with
a ﬁlter paper and ﬂash-frozen [using FEI Vitrobot (Mark
IV)] to obtain ribosomes embedded in a thin layer of
vitreous ice suspended across the holes (Figure 2). The
images were collected at liquid-nitrogen temperature
using the in-house FEI Tecnai F30 (Polara) ﬁeld
emission gun (FEG) transmission cryo electron
Figure 1. Biophysical characterization of human 80S ribosomes puriﬁed from HeLa cells. (A) 15–30% sucrose density gradient proﬁles for 80S, and
dissociated 60S and 40S subunits depicting the separation of components based on density. (B) SEC-MALLS for 80S sample and (C) AUC results
showing the homogeneity of 80S sample, which corresponds to the calculated molecular weight of 4.3 MDa.
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microscope operating at 150 kV acceleration voltage with
a dose of 10–15 electrons per A˚2 at a magniﬁcation of
59 000 on a 4 k 4 k CCD Eagle camera (FEI) resulting in
a ﬁnal step size of 1.82 A˚ per pixel. Another data set was
collected at 150 kV acceleration voltage with magniﬁca-
tion of 93 000 on a CMOS Falcon 1 camera (FEI; installed
as an upgrade on the microscope while this work was
ongoing) resulting in a ﬁnal step size of 1.14 A˚ per pixel
(Table 1). Automatic image acquisition was performed
using EPU software (FEI). After visual inspection only
images with best power-spectra were selected for image
processing. Particle selection was done semi-automatically
in e2boxer.py (EMAN2) with validation of all boxed
particles by visual inspection. Defocus value estimation
and contrast transfer function correction by phase
ﬂipping were done by using the program 2ctf.py from
the EMAN2 software package (37,38). Structure deter-
mination and reﬁnement was done using the EMAN2
software packages (37,38). The resolution of the ﬁnal 3D
structures was estimated by Fourier Shell Correlation (39)
according to the 0.5, 0.14 (40) and one-half-bit (41) criteria
to 13.3, 8.7 and 9.3 A˚ for the empty ribosome consistent
with the features of the maps, while it was 16.5, 11.7 and
11.5 A˚ for ribosome with E-site tRNA, respectively.
Crystallization of human 80S ribosomes
The puriﬁed 80S ribosomes were ﬁltered using Millipore
0.22mm after 7 days of annealing on ice [as for yeast ribo-
somes; (7)], and the sample was kept at room temperature
for an hour before setting up crystallization screens.
Puriﬁed ribosomes (0.35 ml) at 5–9mg/ml were loaded on
one side of The Crystal Former (Microlytic) and 0.35ml of
precipitant were loaded on the other side. A number of
screens were tested including PEGs (Hampton Research),
PEG-Ion pH (Hampton Research), Nucleix (Qiagen) and
Protein Complex (Qiagen) at 4 and 17C. Microcrystals
were obtained with 20% PEG 10K, 100mM Na HEPES,
pH 7.5, or with 15% PEG 20K, 100mM Na HEPES, pH
7.5, at 17C (Figure 3A). Optimization of the crystalliza-
tion conditions with 30% PEG 20K, 10mM Mg(OAc)2
and 100mM Na-HEPES, pH 7.5, allowed obtaining
slightly larger crystals. Apart from the crystal former,
also the crystal Harp (Molecular Dimensions) and clas-
sical glass capillaries of 0.5 and 1mm were tested. These
crystals could not be directly reproduced in sitting drops
(with 1:1 sample/precipitant) with the same conditions.
Therefore, in a concentration range of 5–9mg/ml of
puriﬁed ribosomes, optimization of the PEG 20K con-
centration and other condition with PEG 10K as precipi-
tant, was done to get crystals in sitting drops. This
included commercial screens such as PEGs (Hampton
Research), PEG-Ion pH (Hampton Research), Nucleix
(Qiagen) and Protein Complex (Qiagen). Plate-like
crystals were obtained with 2 ml of 8mg/ml of sample
mixed with 2 ml of 4% PEG 20K, 100mM Na-HEPES,
pH 7.5, and 50mM KSCN. Eighteen percent glycerol or
a series of small PEGs such as 8% PEG 4K, 8% PEG
6K, 8% PEG 8K along with 8% glycerol as cryo-pro-
tectants were tested, with 18% glycerol alone being the
best one found here.
RESULTS
Preparation and characterization of human 80S ribosomes
Because serum starvation is known to inhibit translation
in eukaryotic cell lines (42), we reasoned that this may be a
way to obtain more homogenous monosomes. HeLa cells
were therefore grown in suspension balloons and serum-
starved for 6 h or processed directly. Human 80S ribo-
somes were isolated from the cell lysate after centrifuga-
tion to remove mitochondria and nuclei, and the
supernatant was loaded onto a 30% sucrose cushion.
The pellet obtained was treated with puromycin to
remove nascent peptides bound to the 80S, giving a yield
of 7–8mg of pure ribosomes from 6 l of cells (20–25 108)
after the sucrose gradient (29). The presence of 18S and
28S rRNAs was conﬁrmed by ethidium bromide staining.
Several steps had to be optimized during puriﬁcation to
ensure homogeneity of the sample to be used for structural
studies. Cell lysis being the most important step due to the
presence of numerous proteases was treated with the
maximum precaution. Several detergents such as
CHAPS, NP-40 and Triton X-100 were tried, also
dounce homogenizer was used to see if cell disruption
would work better. However, 0.5% NP-40 turned out to
be the mildest procedure, as monitored by cryo-EM
imaging of 80S particles. The other bottleneck was
removal of sucrose, which is a basic necessity for EM to
ensure a good image contrast (43). For this, different
methods were tried such as (i) centrifugation of the
sucrose gradient fractions and resuspension of the pellet,
(ii) exchanging buffer with a NAP column and then
concentrating the sample and (iii) PEG 20K precipitation.
The fastest, most convenient and least inﬂuencing proced-
ure on ribosome stability was precipitation using PEG
20K, a method also used for yeast ribosome puriﬁcation
(7). Salt composition and concentration (KCl and Mg2+)
were optimized using cryo-EM imaging (see below).
The presence of all ribosomal proteins was conﬁrmed
using mass spectrometry (Supplementary Tables 1 and 2).
It can, however, not be excluded that some loosely bound
ribosomal proteins are present with variable stoichiometry
in the 80S complex because protein peptide fragment oc-
currence depends also on how well the proteins can be







Detector CCD Eagle CMOS Falcon 1
4 k 4 k 4 k 4 k
Voltage 100 kV 300 kV
Pixel size 1.82 A˚ 1.14 A˚
Box size 240 240 512 512
Magniﬁcation 59 k 93 k
Number of particles 15 000 24 000
Total dose 15 e/A˚2 20 e/A˚2
Defocus 0.8 to 3.5 mm 1 to 5 mm
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digested and detected by mass spectrometry. The sample
was analyzed by SEC-MALLS and AUC (Figure 1B and
C). The sedimentation coefﬁcient was determined to be
close to 80S with a single major peak obtained in AUC
corresponding to 4.3 MDa (the theoretical value is 4.2
MDa), a result consistent with the chromatogram from
SEC-MALLS. While the precision of SEC-MALLS and
AUC cannot address whether all ribosomes contain all
ribosomal proteins because of the high molecular weight,
these analytical techniques were useful to monitor the
sample quality throughout the puriﬁcation procedure.
Cryo electron microscopy
To evaluate the homogeneity and monodispersity of the
80S ribosomes, the particle distribution was analyzed
under different preparation conditions using cryo-EM
imaging (Figure 2). This helped in ﬁnding the optimal
conditions for puriﬁcation, the optimal buffer being
150mM KCl and 5mM Mg2+ or less. Buffers with
higher Mg2+ concentration showed aggregation, while
higher KCl concentration increasingly leads to the appear-
ance of the individual ribosomal subunits. The role of
monovalent and divalent cations on subunit association
has been well documented for prokaryotes and to some
extent for eukaryotes as well. Previously, the concentra-
tion of potassium and magnesium in the resuspension
buffer was observed to be crucial (44,45). In our hands,
the sample completely aggregates at 20mM Mg(OAc)2,
while at 5mM and below it is monodisperse, as can be
judged from the even distribution of ribosome particles on
a cryo-EM grid (Figure 2C). This is consistent with the
cellular concentration of magnesium being around 1mM,
which would promote the ribosomes to remain monodis-
perse when not translating. In contrast, the potassium
concentration was found to be critical for the association
of the two ribosomal subunits (46). At 150mM KCl, 80S
ribosomes were found to be stable at a concentration that
compares well with that in cells. Only at signiﬁcantly
higher salt concentrations such as 500mM KCl, the
subunits become dissociated on the sucrose density
gradient (Figure 1A). Consistent with this observation is
the idea that potassium is required for inter-subunit sta-
bility while magnesium ensures proper rRNA folding.
However, at higher concentrations, magnesium promotes
inter-particle contacts, which lead to ribosome aggrega-
tion and precipitation as visualized by cryo-EM imaging.
Using optimized buffers, single-particle cryo-EM data
sets were collected for 80S samples obtained from serum-
starved HeLa cell for two salt concentrations during
Puromycin treatment (150 or 300mM KCl). The serum
starvation is an important step towards getting a clean
homogenous sample as was observed from direct cryo-
EM imaging. Ribosomes isolated from nonstarved cells
show impurities (Figure 2A), while ribosomes isolated
from cells in stationary phase appear to undergo partial
degradation (Figure 2B; for these reasons 3D reconstruc-
tions were not attempted from these samples). Glutamine
starvation also shows ribosomes with either partial deg-
radation or with impurities (Figure 2C). Serum is known
to affect translation because its absence reduces the rate of
in vitro polypeptide synthesis. We observed that on serum
starvation of HeLa cells for 6 h, which leads to cell syn-
chronization, ribosomes appear to be more homogenous,
as can be judged from the cryo-EM images (Figure 2D).
A 3D reconstruction obtained from only 15 000
particles of 80S ribosomes (serum-starved) already
provides a well-deﬁned structure of the human ribosome
with all the major landmarks such as the L1 stalk, the
central protuberance in the large subunit and the head,
beak, body and feet in the small subunit (Figure 2E).
These features are consistent with the human ribosome
structure published in previous studies (13,47). This 80S
structure was obtained from ribosomes that went through
a high-salt (300mM) washing step during puromycin
treatment right after the sucrose cushion. Next, to keep
the salt concentration constant throughout the
puriﬁcation process, we decided to skip the high-salt
washing step and maintain 150mM KCl throughout.
Figure 2. Cryo electron micrograph depicting the distribution of 80S
particles at 59k magniﬁcation, collected using a Polara F-30 electron
microscope. The ribosomes were isolated from Hela cells (A) under
normal growth conditions (B) in stationary phase of growth (C) after
glutamine starvation (D) after serum-starvation (inset shows the
zoomed-in view for individual ribosomes). (E) The cryo-EM structure
of empty human 80S and with (F) E-site tRNA; both isolated
from HeLa cells; under high and low KCl concentration during
Puromycin treatment, respectively; color code: 40S golden, 60S blue,
tRNA red.
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Interestingly, the cryo-EM reconstruction from such
samples reveals the presence of an E-site tRNA
(Figure 2F), a well-deﬁned L1 stalk next to the E-site
tRNA and well-ordered P-proteins (these regions are
largely disordered in the high-salt washed ribosomes).
This shows that the absence of a high-salt step allows
maintaining an endogenous tRNA in the E-site, while
mRNA and peptide are absent as revealed by the com-
parison of the corresponding cryo-EM reconstructions.
The lower resolution of the E-site tRNA complex as
compared with that of the empty ribosome may be due
to ribosome subpopulations with different conformations,
which would be compatible with the observation of
different conformations in the asymmetric unit of yeast
(7) and T. thermophila ribosomes (48).
Crystallization of the human 80S ribosome
The high homogeneity of the sample allowed us obtaining
crystals in the microlytic crystal former capillaries as well
as in a crystal harp, and also in sitting drops. After
screening several conditions from PEGs (Hampton),
PEG Ion pH (Hampton) and Protein complex (Qiagen)
screens at 4 and 17C, initial hits of microcrystals were
obtained in capillaries with two conditions: 20% PEG
10K, 0.1 M Na HEPES, pH 7.5, and 15% PEG 20K,
0.1 M Na HEPES, pH 7.5, at 17C. An increasing
gradient of microcrystals (10–30 mm in size) could be
observed from the precipitant loading side to the protein
loading side. Optimization of the conditions provided
larger crystals with 30% PEG 20K, 0.1 M Na HEPES,
pH 7.5, and 10mMMg(OAc)2 (Figure 3A). In situ diffrac-
tion from capillaries was attempted at the PX III beamline
of the Swiss Light Source (SLS) synchrotron at room tem-
perature as well as under cryo conditions (by freezing the
tip of the capillary containing crystals, tested on beamline
PX I). While no diffraction spots could be seen, this was a
ﬁrst indication that these crystals were not salt. However,
owing to the complexity of handling them in capillaries
they could not be mounted in loops. Direct freezing of
capillaries was successful with respect to cryo conditions
(no ice rings), but showed no diffraction (either no diffrac-
tion or high background due to the large mass of solvent
in the capillary). Reproducing crystals under the same
conditions in sitting drops was not successful probably
because capillaries work on the principle of counter diffu-
sion, which is strikingly different from vapour diffusion
used in sitting or hanging drops in terms of the kinetics of
equilibration and concentration used. Therefore, PEG
20K concentration was varied in a large range for
forming crystals in sitting drops. Crystals with plate
morphology were ﬁnally obtained in sitting drops
(Figure 3B) with 4% PEG 20K, 100mM Na HEPES,
pH 7.5, and 50mM KSCN in the reservoir. For crystal
handling, mounting in loops (Figure 3C) and freezing,
overnight stabilization with increasing PEG 20K in reser-
voir to 6 or 8% was tried, to stabilize crystals but resulted
in no diffraction. Adding medium-sized PEGs such as
PEG 4K, 6K or 8K with or without glycerol, either
resulted in no diffraction or did not improve diffraction.
First diffraction spots up to 60 A˚ could be observed for
small, thin and fragile crystals (60 10 2 mm, SLS
beamline PX I) with 16% glycerol as cryo-protectant
added directly into the crystallization drop. With
notably larger crystals (100 50 5 mm) diffraction
improved to 26 A˚ (at SLS beamline PX I) showing a full
reciprocal lattice (Figure 3E). For this and all subsequent
experiments, the cryo-protectant was increased in steps of
2–4% to prevent osmotic shock damage to the crystal. The
sample stability under crystallization conditions was
veriﬁed using ethidium bromide–stained agarose gels for
presence of rRNA after 2–4 weeks of sample preparation
(Figure 3D). The gel shows 18S and 28S rRNA bands, as
do ribosomes that were stored at 80C after preparation.
A full data set could be collected to 40 A˚ resolution
(Figure 3E and Table 2) from which the cell parameters,
space group, Matthews coefﬁcient, solvent content and
number of molecules in the asymmetric unit could be
derived (see below). Data were collected on a Pilatus
detector at the SLS PX II beamline with a 10 30 mm or
10 50 mm X-ray beam and 0.2 oscillations, detector
distance 1200mm, wavelength 0.997 A˚. Both 80S
complexes with or without endogenous E-site tRNA, as
characterized by cryo-EM (Figure 2), were used for crys-
tallization assays. However, crystals grew only for ribo-
somes prepared at 150mM KCl throughout, i.e., without
any E-site tRNA washing step. This indicates that the
crystals contain E-site tRNA, and that its presence could
favor crystallization.
DISCUSSION
Human ribosomes represent an important target for struc-
tural studies because of health implications such as side
effects of current antibiotics. While cryo-EM structures of
human ribosomes have been recently reported to 4–5 A˚
resolution (18), no crystal structures are upcoming for
now. Obtaining crystals of human ribosomes represents
a major challenge, and any ﬁrst clue on puriﬁcation and
crystallization conditions would be helpful, even if initial
crystals usually diffract weakly. In a ﬁrst strong effort in
this direction, crystals of the human 80S ribosome were
obtained using a nonstandard integrated structural
biology approach, using a variety of established methods
in a synergistic way rather than individually. This included
establishing a detailed method for large-scale preparation
of homogenous 80S ribosomes extracted from HeLa cells,
which can be grown in large quantities and from which the
ribosome puriﬁcation is less complicated than from blood
(18) or human placenta (29), majorly due to the ease of
availability of HeLa cells and less tedious methods of
initial lysis. Placenta handling requires immediate isola-
tion of ribosomes, due to the inherent presence of large
RNase contaminations; also, the lysis itself is tedious,
requiring gauze ﬁltration and dounce homogenizer
owing to the presence of connective tissues. Similarly,
blood samples require a ﬁcoll-hypaque density-gradient
centrifugation to separate out lymphocytes. Such exten-
sive methods are not needed when handling HeLa cells:
the usage of a detergent is sufﬁcient for cell lysis without
any additional puriﬁcation step. Contaminants like
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Figure 3. (A) First human 80S ribosome crystals obtained in the capillaries of a crystal harp. (B) Crystals with plate morphology reproduced in
sitting drops that diffracted up to 26 A˚, most are seen on the edge and thus give the impression of rods. (C) 80S crystal mounted in a cryogenic loop,
tested for X-ray diffraction at the PX-II beamline at SLS. (D) Agarose gel depicting the sample stability under crystallization conditions as monitored
by the presence of 18S and 28S rRNA. Lane 1 shows control ribosomes stored at 80C, lanes 2 and 3 show ribosomes incubated with or without
precipitant, respectively, for 4 weeks at 4C. (E) The diffraction pattern shows a full reciprocal lattice with cell parameters of approximately
a=406 A˚, b=785 A˚, c=977 A˚, with resolution rings indicated at 23, 30 and 40 A˚. The inset shows diffraction spots extending to 26 A˚ resolution.
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ferritin in placenta are difﬁcult to get rid of and tend to be
co-puriﬁed with ribosomes. Ribosomes from HeLa cells
analyzed in the present study neither have these contam-
inants nor these RNA and protein degradation issues
known for placental ribosomes. The next two steps follow-
ing cell lysis in the puriﬁcation procedure are usually used
for standard ribosome puriﬁcations: sucrose cushion and a
gradient to obtain homogenous 80S ribosomes, which
leads to an additional sucrose removal step. Here,
human 80S were puriﬁed using PEG20K precipitation,
which is a more straightforward method [used also for
yeast ribosomes (7)]. The detailed standardized puriﬁca-
tion protocol described in this work is a prerequisite for
structural studies of the human ribosome and has allowed
obtaining ﬁrst crystals that are highly reproducible from
various cell culture batches. A typical feature of the work
presented here is the biophysical characterization by SEC-
MALLS, AUC and includes the usage of sucrose gradi-
ents. For example, SEC-MALLS and AUC helped to
check the sample solubility and stability in different
ionic conditions, along with molecular weight detection
to check for presence of aggregates or dissociated
subunits. Also, the exploration of various puriﬁcation pro-
cedures, optimized by monitoring sample purity and
homogeneity (in particular absence of aggregation)
through direct nondenaturing cryo-EM visualization of
the ribosome particles in conjunction with crystallization
trials is a prominent feature of this work and has been the
key in obtaining ﬁrst 80S crystals, thanks to the unprece-
dented combined usage of cryo-EM and crystallography.
Rather than performing a detailed structural analysis,
cryo-EM was used for examining the sample composition
(presence of structured rRNA’s and ribosomal proteins,
presence of tRNA’s) and structural integrity from quickly
obtainable medium-resolution cryo-EM maps (using data
sets 10 times smaller than used for high-resolution struc-
tures reported previously) with the aim of obtaining crys-
tallizable material. This structural analysis revealed the
presence of E-site tRNA in human 80S ribosomes depend-
ing on a subtle difference in the puriﬁcation protocol, that
is the salt concentration used during Puromycin
treatment. The salt-sensitivity suggests that this E-site
tRNA binds in a nonspeciﬁc manner (50), probably also
because no mRNA is present. This provides a valuable
tool for obtaining either completely empty or E-site
tRNA bound ribosomes, which can be used separately
for further complex reconstitutions. For crystallization,
we show that the presence of the E-site tRNA in human
80S ribosomes is helpful if not required because crystals
could not be obtained with completely empty 80S ribo-
somes. This is probably because the E-site tRNA stabilizes
the local ribosome structure, notably in the regions of the
L1 and P-stalk proteins (51). The resulting conformation
is compatible with the formation of inter-particle contacts
in the crystal, as illustrated by the observed crystal nucle-
ation and crystal growth, but different conformations may
still be present in the asymmetric unit, as observed for
yeast (7) and T. thermophila ribosomes (48). A related
interesting aspect is that crystals can be obtained despite
the presence of huge RNA ES elements, which protrude
from the core structure (52); this is remarkable in terms of
crystal packing, suggesting that ESs do not hamper crys-
tallization in a signiﬁcant way.
The use of capillaries for crystallization of large
macromolecular complexes has been underexploited in
the recent past, even though it is known to work well
for smaller proteins (53,54). This work shows that uncon-
ventional methods like these can be helpful for initial
screening of crystallization conditions, especially for in-
herently challenging samples and provide ﬁrst hits to be
further pursued in thicker capillaries or crystallization
drops. The morphology of the human 80S ribosome
crystals that form thin plates resembles that of early
crystals of T. thermophilus ribosomes (55,56). After stabil-
ization to reduce the fragile character of the thin crystals,
they could be mounted in cryo loops in a rather straight-
forward manner. The crystals obtained diffract X-rays at a
high-brilliance synchrotron source to up to 26 A˚ reso-
lution, and show clear and ﬁne diffraction spots along
the reﬂection series of the diffraction pattern. The clean
diffraction pattern also reveals that the crystals are
monocrystalline, i.e. the crystal plates obtained under
the crystallization conditions described here do not form
multiple layers of distinct crystals, a phenomenon that
otherwise occurs rather often for crystals with plate
morphology. The diffraction pattern could be indexed,
revealing that the crystals belong to the centric ortho-
rhombic Bravais lattice type (space groups C222 or
C2221, which have eight asymmetric units). The cell par-
ameters of approximately a=406 A˚, b=785 A˚ and
c=977 A˚ clearly indicate the presence of a large
complex compatible with the Mw=4.3 MDa estimated
from the AUC and SEC-MALLS data. The calculation
of the Matthews coefﬁcient gives a value of Vm=3.0
with three molecules in the asymmetric unit and a
solvent content of 59%, or Vm=2.3 with four molecules
and 45% solvent [comparable with other ribosome
crystals (57,58); the third alternative would give
Vm=4.5 with two molecules and a rather high solvent
content of 73%]. The presence of three or four molecules
in the asymmetric unit may be useful for noncrystallo-
graphic symmetry averaging, provided the ribosome
Table 2. Data collection statistics of a full data set collected from
two regions of a single crystal at the SLS PX II beamline
X-ray data collection Human 80S
Beamline PX II (SLS)
Space group C222(1)
Cell dimensions
a, b, c (A˚) 406.41, 784.99, 976.95
angles () 90, 90, 90
Resolution (A˚) 150–42.0
Last shell (43.9–42.0)
Rsym (%) 7.5 (74.1)
Reﬂections 5022
Completeness (%) 96.8 (88.6)
Redundancy 4.1 (3.2)
I/ai 7.7 (1.8)
Numbers in brackets refer to the highest resolution shell. Rsym is
deﬁned according to XDS (49).
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conformations are sufﬁciently similar. The small clean dif-
fraction spots help in separating the spots and integrating
the data, especially in the more challenging b- and c-dir-
ections. Because of the large cell parameters, ﬁne-slicing
was used with angular increments of 0.1–0.2 per frame in
combination with a high-sensitivity and low readout noise
pixel detector (Pilatus). In conclusion, the crystals are of
excellent quality and diffraction data could be collected
and processed, providing a ﬁrst full data set at 42 A˚ reso-
lution (Table 2). Their diffraction power, however, is
limited (best resolution seen is 26 A˚ up to now, Figure
3E) most likely because of the little thickness of the
crystals, which varies between 5 and 10 mm. In the
future, it might be worth exploring conditions that
promote crystal growth in the third dimension.
Possibilities worth considering comprise further reﬁned
crystallization conditions such as the usage of additive
screens and detergents, or removal of surface-exposed
parts that may hamper further crystal growth such as
loosely bound ribosomal proteins or part of the ES
elements whose removal could help in obtaining larger
crystals (some proteins could be removed by differential
salt-wash as illustrated for the E-site tRNA, a procedure
used for S1-removal; (59, 60) or cell line engineering such
as done for L9-removal (61), which may be difﬁcult to
apply to human cells though. Although serum starvation
was used (to synchronize cells), the ribosomes do not have
any starvation factors bound, as compared with yeast
ribosomes (7) or ribosomes isolated from blood (18),
which have Stm-1 and Stm-1 like factors bound, respect-
ively. This can be an advantage when forming translation
complexes with mRNA and ribosomal translation factors
for future crystallization or cryo-EM studies. Another
aspect which we begun to analyze here is to reﬁne the
procedure for crystal stabilization and cryo-protection
and reduce crystal mosaicity; controlled dehydration
may also improve the diffraction of the crystals (7). In
any case, while the crystals described here are diffracting
relatively poorly and will need to be improved to reach a
stronger diffraction power, they are the very ﬁrst human
ribosome crystals reported to our knowledge. This shows
that the optimized puriﬁcation procedure described herein
provides crystallizable human ribosomes, a sine-qua-non
condition for further crystallography work. The present
work thus paves the way for future high-resolution
crystal structures of the human ribosome, in isolated
form or as complexes with mRNA, tRNAs and transla-
tion factors, with a major potential impact for studying
molecular mechanisms and exploring medical applications
in the ribosome ﬁeld.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
ACKNOWLEDGEMENTS
We would like to thank Meitian Wang and Florian
Dworkowski from the Swiss Light Source for their
excellent support on the PX I, II and III beamlines,
Jean-Francois Me´ne´tret for discussions on cryo-EM
image processing and Betty Heller and Camille Apfel for
support from the IGBMC cell culture facility, and the
members of the IGBMC facilities, in particular the
Structural Biology Platform, for their support. Authors
contributions: H.K.: conception and design, experimental
acquisition and interpretation of data, data processing,
manuscript preparation; A.G.M.: cryo-EM data collec-
tion, image processing and analysis; L.M.: Hela cell
cultures growth and maintenance; I.B.: acquisition and
analysis of SEC-MALLS data; C.B.: acquisition of AUC
data; S.S.: conception and design; B.P.K.: conception and
design, crystal mounting, X-ray data processing, data
analysis and manuscript preparation.
FUNDING
European Research Council (ERC Starting Grant N
243296 TRANSLATIONMACHINERY); the Centre
National pour la Recherche Scientiﬁque (CNRS);
French Infrastructure for Integrated Structural Biology
(FRISBI) [ANR-10-INSB-05-01]; Instruct as part of the
European Strategy Forum on Research Infrastructures
(ESFRI); and Alsace Region, the Fondation pour la
Recherche Me´dicale (FRM), INSERM, CNRS and the
Association pour la Recherche sur le Cancer (ARC)
(toward electron microscope facility). Funding for open
access charge: ERC.
Conﬂict of interest statement. None declared.
REFERENCES
1. Dube,P., Bacher,G., Stark,H., Mueller,F., Zemlin,F., van Heel,M.
and Brimacombe,R. (1998) Correlation of the expansion segments
in mammalian rRNA with the ﬁne structure of the 80 S
ribosome; a cryoelectron microscopic reconstruction of the rabbit
reticulocyte ribosome at 21 A resolution. J. Mol. Biol., 279,
403–421.
2. Chen,I.J., Wang,I.A., Tai,L.R. and Lin,A. (2008) The role of
expansion segment of human ribosomal protein L35 in nuclear
entry, translation activity, and endoplasmic reticulum docking.
Biochem. Cell Biol., 86, 271–277.
3. Becker,T., Franckenberg,S., Wickles,S., Shoemaker,C.J.,
Anger,A.M., Armache,J.P., Sieber,H., Ungewickell,C.,
Berninghausen,O., Daberkow,I. et al. (2012) Structural basis of
highly conserved ribosome recycling in eukaryotes and archaea.
Nature, 482, 501–506.
4. Klaholz,B.P. (2011) Molecular recognition and catalysis in
translation termination complexes. Trends Biochem. Sci., 36,
282–292.
5. Jackson,R.J., Hellen,C.U. and Pestova,T.V. (2010) The
mechanism of eukaryotic translation initiation and principles of
its regulation. Nat. Rev. Mol. Cell Biol., 11, 113–127.
6. Klaholz,B.P., Myasnikov,A.G. and van Heel,M. (2004)
Visualization of release factor 3 on the ribosome during
termination of protein synthesis. Nature, 427, 862–865.
7. Ben-Shem,A., Garreau de Loubresse,N., Melnikov,S., Jenner,L.,
Yusupova,G. and Yusupov,M. (2011) The structure of the
eukaryotic ribosome at 3.0 A resolution. Science, 334, 1524–1529.
8. Klinge,S., Voigts-Hoffmann,F., Leibundgut,M., Arpagaus,S. and
Ban,N. (2011) Crystal structure of the eukaryotic 60S ribosomal
subunit in complex with initiation factor 6. Science, 334, 941–948.
9. Rabl,J., Leibundgut,M., Ataide,S.F., Haag,A. and Ban,N. (2011)
Crystal structure of the eukaryotic 40S ribosomal subunit in
complex with initiation factor 1. Science, 331, 730–736.
PAGE 9 OF 11 Nucleic Acids Research, 2014, Vol. 42, No. 6 e49
10. Verschoor,A., Srivastava,S., Grassucci,R. and Frank,J. (1996)
Native 3D structure of eukaryotic 80s ribosome: morphological
homology with E. coli 70S ribosome. J. Cell Biol., 133, 495–505.
11. Armache,J.P., Jarasch,A., Anger,A.M., Villa,E., Becker,T.,
Bhushan,S., Jossinet,F., Habeck,M., Dindar,G., Franckenberg,S.
et al. (2010) Cryo-EM structure and rRNA model of a
translating eukaryotic 80S ribosome at 5.5-A resolution. Proc.
Natl Acad. Sci. USA, 107, 19748–19753.
12. Spahn,C.M., Jan,E., Mulder,A., Grassucci,R.A., Sarnow,P. and
Frank,J. (2004) Cryo-EM visualization of a viral internal
ribosome entry site bound to human ribosomes: the IRES
functions as an RNA-based translation factor. Cell, 118, 465–475.
13. Spahn,C.M., Beckmann,R., Eswar,N., Penczek,P.A., Sali,A.,
Blobel,G. and Frank,J. (2001) Structure of the 80S ribosome
from Saccharomyces cerevisiae–tRNA-ribosome and subunit-
subunit interactions. Cell, 107, 373–386.
14. Chandramouli,P., Topf,M., Menetret,J.F., Eswar,N., Cannone,J.J.,
Gutell,R.R., Sali,A. and Akey,C.W. (2008) Structure of the
mammalian 80S ribosome at 8.7 A resolution. Structure, 16,
535–548.
15. Taylor,D., Unbehaun,A., Li,W., Das,S., Lei,J., Liao,H.Y.,
Grassucci,R.A., Pestova,T.V. and Frank,J. (2012) Cryo-EM
structure of the mammalian eukaryotic release factor eRF1-eRF3-
associated termination complex. Proc. Natl Acad. Sci. USA, 109,
18413–18418.
16. Sengupta,J., Nilsson,J., Gursky,R., Spahn,C.M., Nissen,P. and
Frank,J. (2004) Identiﬁcation of the versatile scaffold protein
RACK1 on the eukaryotic ribosome by cryo-EM. Nat. Struct.
Mol. Biol., 11, 957–962.
17. Halic,M., Becker,T., Frank,J., Spahn,C.M. and Beckmann,R.
(2005) Localization and dynamic behavior of ribosomal protein
L30e. Nat. Struct. Mol. Biol., 12, 467–468.
18. Anger,A.M., Armache,J.P., Berninghausen,O., Habeck,M.,
Subklewe,M., Wilson,D.N. and Beckmann,R. (2013) Structures of
the human and Drosophila 80S ribosome. Nature, 497, 80–85.
19. Becker,T., Bhushan,S., Jarasch,A., Armache,J.P., Funes,S.,
Jossinet,F., Gumbart,J., Mielke,T., Berninghausen,O., Schulten,K.
et al. (2009) Structure of monomeric yeast and mammalian Sec61
complexes interacting with the translating ribosome. Science, 326,
1369–1373.
20. Taylor,D.J., Devkota,B., Huang,A.D., Topf,M., Narayanan,E.,
Sali,A., Harvey,S.C. and Frank,J. (2009) Comprehensive
molecular structure of the eukaryotic ribosome. Structure, 17,
1591–1604.
21. Becker,T., Armache,J.P., Jarasch,A., Anger,A.M., Villa,E.,
Sieber,H., Motaal,B.A., Mielke,T., Berninghausen,O. and
Beckmann,R. (2011) Structure of the no-go mRNA decay
complex Dom34-Hbs1 bound to a stalled 80S ribosome. Nat.
Struct. Mol. Biol., 18, 715–720.
22. Hashem,Y., des Georges,A., Fu,J., Buss,S.N., Jossinet,F., Jobe,A.,
Zhang,Q., Liao,H.Y., Grassucci,R.A., Bajaj,C. et al. (2013) High-
resolution cryo-electron microscopy structure of the Trypanosoma
brucei ribosome. Nature, 494, 385–389.
23. Yonath,A. (2005) Antibiotics targeting ribosomes: resistance,
selectivity, synergism and cellular regulation. Annu. Rev. Biochem.,
74, 649–679.
24. Franceschi,F. and Duffy,E.M. (2006) Structure-based drug design
meets the ribosome. Biochem. Pharmacol., 71, 1016–1025.
25. Carter,A.P., Clemons,W.M., Brodersen,D.E., Morgan-
Warren,R.J., Wimberly,B.T. and Ramakrishnan,V. (2000)
Functional insights from the structure of the 30S ribosomal
subunit and its interactions with antibiotics. Nature, 407, 340–348.
26. Brodersen,D.E., Clemons,W.M. Jr, Carter,A.P., Morgan-
Warren,R.J., Wimberly,B.T. and Ramakrishnan,V. (2000) The
structural basis for the action of the antibiotics tetracycline,
pactamycin, and hygromycin B on the 30S ribosomal subunit.
Cell, 103, 1143–1154.
27. Wilson,D.N., Harms,J.M., Nierhaus,K.H., Schlunzen,F. and
Fucini,P. (2005) Species-speciﬁc antibiotic-ribosome
interactions: implications for drug development. Biol.Chem., 386,
1239–1252.
28. Kannan,K. and Mankin,A.S. (2011) Macrolide antibiotics in the
ribosome exit tunnel: species-speciﬁc binding and action. Ann. N.
Y. Acad. Sci., 1241, 33–47.
29. Matasova,N.B., Myltseva,S.V., Zenkova,M.A., Graifer,D.M.,
Vladimirov,S.N. and Karpova,G.G. (1991) Isolation of ribosomal
subunits containing intact rRNA from human placenta:
estimation of functional activity of 80S ribosomes. Anal.
Biochem., 198, 219–223.
30. Jan,E. and Sarnow,P. (2002) Factorless ribosome assembly on the
internal ribosome entry site of cricket paralysis virus. J. Mol.
Biol., 324, 889–902.
31. Tyulkina,L.G. and Mankin,A.S. (1984) Inhibition of ribonuclease
contamination in preparations of T4 RNA ligase, polynucleotide
kinase, and bacterial alkaline phosphatase with bentonite. Anal.
Biochem., 138, 285–290.
32. Jacoli,G.G., Ronald,W.P. and Lavkulich,L. (1973) Inhibition of
ribonuclease activity by bentonite. Can. J. Biochem., 51,
1558–1565.
33. Belin,S., Hacot,S., Daudignon,L., Therizols,G., Pourpe,S.,
Mertani,H.C., Rosa-Calatrava,M. and Diaz,J.J. (2010)
Puriﬁcation of ribosomes from human cell lines. Curr. Protoc.
Cell Biol., Chapter 3, Unit 3.40.
34. Blobel,G. and Sabatini,D. (1971) Dissociation of mammalian
polyribosomes into subunits by puromycin. Proc. Natl Acad. of
Sci. USA, 68, 390–394.
35. Lebowitz,J., Lewis,M.S. and Schuck,P. (2002) Modern analytical
ultracentrifugation in protein science: a tutorial review. Protein
Sci., 11, 2067–2079.
36. Schuck,P. (2000) Size-distribution analysis of macromolecules by
sedimentation velocity ultracentrifugation and lamm equation
modeling. Biophys. J., 78, 1606–1619.
37. Ludtke,S.J., Baldwin,P.R. and Chiu,W. (1999) EMAN:
semiautomated software for high-resolution single-particle
reconstructions. J. Struct. Biol., 128, 82–97.
38. Tang,G., Peng,L., Baldwin,P.R., Mann,D.S., Jiang,W., Rees,I.
and Ludtke,S.J. (2007) EMAN2: an extensible image processing
suite for electron microscopy. J. Struct. Biol., 157, 38–46.
39. Saxton,W.O. and Baumeister,W. (1982) The correlation averaging
of a regularly arranged bacterial cell envelope protein. J.
Microsc., 127, 127–138.
40. Rosenthal,P.B. and Henderson,R. (2003) Optimal determination
of particle orientation, absolute hand, and contrast loss in single-
particle electron cryomicroscopy. J. Mol. Biol., 333, 721–745.
41. van Heel,M. and Schatz,M. (2005) Fourier shell correlation
threshold criteria. J. Struct. Biol., 151, 250–262.
42. Kuwano,M., Endo,H. and Ikehera,Y. (1973) Differences in RNA
formation and polyribosome metabolism in serum-starved normal
and transformed cells. Cancer Res., 33, 2965–2971.
43. Grassucci,R.A., Taylor,D.J. and Frank,J. (2007) Preparation of
macromolecular complexes for cryo-electron microscopy. Nat.
Protoc., 2, 3239–3246.
44. Shenvi,C.L., Dong,K.C., Friedman,E.M., Hanson,J.A. and
Cate,J.H. (2005) Accessibility of 18S rRNA in human 40S
subunits and 80S ribosomes at physiological magnesium ion
concentrations—implications for the study of ribosome dynamics.
RNA, 11, 1898–1908.
45. Moore,M.N. and Spremulli,L.L. (1985) Effects of cations and
cosolvents on eukaryotic ribosomal subunit conformation.
Biochemistry, 24, 191–196.
46. Sperrazza,J.M., Russell,D.W. and Spremulli,L.L. (1980)
Reversible dissociation of wheat germ ribosomal subunits: cation-
dependent equilibria and thermodynamic parameters.
Biochemistry, 19, 1053–1058.
47. Beckmann,R., Spahn,C.M., Frank,J. and Blobel,G. (2001) The
active 80S ribosome-Sec61 complex. Cold Spring Harb. Symp.
Quant. Biol., 66, 543–554.
48. Weisser,M., Voigts-Hoffmann,F., Rabl,J., Leibundgut,M. and
Ban,N. (2013) The crystal structure of the eukaryotic 40S
ribosomal subunit in complex with eIF1 and eIF1A. Nat. Struct.
Mol. Biol., 20, 1015–1017.
49. Kabsch,W. (2010) Xds. Acta Crystallogr. D Biol. Crystallogr., 66,
125–132.
50. Nierhaus,K.H. (2006) Decoding errors and the involvement of the
E-site. Biochimie, 88, 1013–1019.
51. Fei,J., Kosuri,P., MacDougall,D.D. and Gonzalez,R.L. Jr (2008)
Coupling of ribosomal L1 stalk and tRNA dynamics during
translation elongation. Mol. Cell, 30, 348–359.
e49 Nucleic Acids Research, 2014, Vol. 42, No. 6 PAGE 10 OF 11
52. Melnikov,S., Ben-Shem,A., Garreau de Loubresse,N., Jenner,L.,
Yusupova,G. and Yusupov,M. (2012) One core, two shells:
bacterial and eukaryotic ribosomes. Nat. Struct. Mol. Biol., 19,
560–567.
53. Lorber,B., Sauter,C., Theobald-Dietrich,A., Moreno,A.,
Schellenberger,P., Robert,M.C., Capelle,B., Sanglier,S., Potier,N.
and Giege,R. (2009) Crystal growth of proteins, nucleic acids,
and viruses in gels. Prog. Biophys. Mol. Biol., 101, 13–25.
54. Giege,R. and Sauter,C. (2010) Biocrystallography: past, present,
future. HFSP J., 4, 109–121.
55. Yonath,A., Glotz,C., Gewitz,H.S., Bartels,K.S., von Bohlen,K.,
Makowski,I. and Wittmann,H.G. (1988) Characterization of
crystals of small ribosomal subunits. J. Mol. Biol., 203, 831–834.
56. Yusupov,M.M., Yusupova,G.Z., Baucom,A., Lieberman,K.,
Earnest,T.N., Cate,J.H. and Noller,H.F. (2001) Crystal structure
of the ribosome at 5.5 A resolution. Science, 292, 883–896.
57. Gao,Y.G., Selmer,M., Dunham,C.M., Weixlbaumer,A.,
Kelley,A.C. and Ramakrishnan,V. (2009) The structure of the
ribosome with elongation factor G trapped in the
posttranslocational state. Science, 326, 694–699.
58. Ben-Shem,A., Jenner,L., Yusupova,G. and Yusupov,M. (2010)
Crystal structure of the eukaryotic ribosome. Science, 330,
1203–1209.
59. Clemons,W.M. Jr, Brodersen,D.E., McCutcheon,J.P., May,J.L.,
Carter,A.P., Morgan-Warren,R.J., Wimberly,B.T. and
Ramakrishnan,V. (2001) Crystal structure of the 30 S ribosomal
subunit from Thermus thermophilus: puriﬁcation, crystallization
and structure determination. J. Mol. Biol., 310, 827–843.
60. Duval,M., Korepanov,A., Fuchsbauer,O., Fechter,P., Haller,A.,
Fabbretti,A., Choulier,L., Micura,R., Klaholz,B.P., Romby,P.
et al. (2013) Escherichia coli Ribosomal Protein S1 Unfolds
Structured mRNAs Onto the Ribosome for Active Translation
Initiation. PLoS Biol., 11, e1001731.
61. Selmer,M., Gao,Y.G., Weixlbaumer,A. and Ramakrishnan,V.
(2012) Ribosome engineering to promote new crystal forms. Acta
Crystallogr. D Biol. Crystallogr., 68, 578–583.
PAGE 11 OF 11 Nucleic Acids Research, 2014, Vol. 42, No. 6 e49
